Skip to content
FCF Fox Corporate Finance GmbH
FCF Fox Corporate Finance GmbH
  • About FCF
    • Business
    • Team
    • History
    • Facts
    • Philosophy
  • Business Units
    • FCF MidCap
    • FCF DeepTech
    • FCF Healthcare & Life Sciences
  • References
    • Testimonials
    • Transactions
  • Research
    • FCF MidCap Market Research
      • FCF Interest & Corporate Loan Monitor
      • FCF Valuation Monitor
      • FCF Bank Monitor
      • FCF Sector Monitor
    • FCF DeepTech Research
      • FCF Robotics Venture Capital Report
      • FCF CleanTech Venture Capital Report
      • FCF Advanced Manufacturing Venture Capital Report
      • FCF IoT Venture Capital Report
    • FCF Healthcare & Life Sciences Research
      • FCF Healthcare & Life Sciences Venture Capital Monitor – Europe
      • FCF Healthcare & Life Sciences Venture Capital Monitor – USA
  • Career
  • Contact
FCF Fox Corporate Finance GmbH
  • About FCF
    • Business
    • Team
    • History
    • Facts
    • Philosophy
  • Business Units
    • FCF MidCap
    • FCF DeepTech
    • FCF Healthcare & Life Sciences
  • References
    • Testimonials
    • Transactions
  • Research
    • FCF MidCap Market Research
      • FCF Interest & Corporate Loan Monitor
      • FCF Valuation Monitor
      • FCF Bank Monitor
      • FCF Sector Monitor
    • FCF DeepTech Research
      • FCF Robotics Venture Capital Report
      • FCF CleanTech Venture Capital Report
      • FCF Advanced Manufacturing Venture Capital Report
      • FCF IoT Venture Capital Report
    • FCF Healthcare & Life Sciences Research
      • FCF Healthcare & Life Sciences Venture Capital Monitor – Europe
      • FCF Healthcare & Life Sciences Venture Capital Monitor – USA
  • Career
  • Contact

LS SPAC Monitor

FCF Life Sciences in the Börse Online magazine | 19. April 2021

FCF Life Sciences in the Börse Online magazine | 19. April 2021 The Life Sciences team at FCF Fox Corporate Finance has recently published an analysis on Special Purpose Acquisition Companies (SPACs) with a focus … Read more

FCF Life Sciences: Boom Bei Healthcare-SPACS Ungebrochen | GoingPublic 13.04.2021

Der Boom um Special Purpose Acquisition Companies, auch SPACs genannt, setzt sich 2021 ungebremst fort. Lag die Zahl der SPAC-Börsengänge im gesamten Jahr 2020 noch bei 306 SPAC-IPOs, liegt sie in den ersten drei Monaten … Read more

Unsere letzten Beiträge

  • FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 03/2025 published
  • FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 03/2025 published
  • FCF Bank Monitor – Q1 2025 published
  • FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 02/2025 published
  • FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 02/2025 published
  • FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 01/2025 published
  • FCF Interest & Corporate Loan Monitor Q4/2024 published
  • FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 12/2024 published
  • FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 12/2024 published
  • FCF Valuation Monitor – Q4 2024 published
FCF Fox Corporate Finance GmbH • Maximilianstr. 12-14 • 80539 Munich, Germany • T: +49-89-20 60 409-0 • Imprint • Data Protection • LinkedIn • Xing
Scroll Up